BlackRock’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158M | Sell |
|
|||||
|
2025
Q1 | $163M | Sell |
|
|||||
|
2024
Q4 | $159M | Buy |
|
|||||
|
2024
Q3 | $213M | Sell |
|
|||||
|
2024
Q2 | $187M | Sell |
|
|||||
|
2024
Q1 | $228M | Buy |
|
|||||
|
2023
Q4 | $178M | Sell |
|
|||||
|
2023
Q3 | $139M | Buy |
|
|||||
|
2023
Q2 | $131M | Buy |
|
|||||
|
2023
Q1 | $139M | Buy |
|
|||||
|
2022
Q4 | $133M | Sell |
|
|||||
|
2022
Q3 | $92M | Buy |
|
|||||
|
2022
Q2 | $100M | Sell |
|
|||||
|
2022
Q1 | $116M | Buy |
|
|||||
|
2021
Q4 | $105M | Buy |
|
|||||
|
2021
Q3 | $111M | Sell |
|
|||||
|
2021
Q2 | $134M | Sell |
|
|||||
|
2021
Q1 | $140M | Buy |
|
|||||
|
2020
Q4 | $56.9M | Buy |
|
|||||
|
2020
Q3 | $58.5M | Sell |
|
|||||
|
2020
Q2 | $49.3M | Buy |
|
|||||
|
2020
Q1 | $40.8M | Sell |
|
|||||
|
2019
Q4 | $52.8M | Buy |
|
|||||
|
2019
Q3 | $29.4M | Buy |
|
|||||
|
2019
Q2 | $32.7M | Buy |
|
|||||
|
2019
Q1 | $35.2M | Sell |
|
|||||
|
2018
Q4 | $45M | Buy |
|
|||||
|
2018
Q3 | $35.5M | Buy |
|
|||||
|
2018
Q2 | $53.7M | Buy |
|
|||||
|
2018
Q1 | $50.6M | Buy |
|
|||||
|
2017
Q4 | $36.3M | Buy |
|
|||||
|
2017
Q3 | $19.8M | Buy |
|
|||||
|
2017
Q2 | $23.2M | Buy |
|
|||||
|
2017
Q1 | $14.9M | Buy |
|
|||||
|
2016
Q4 | $9K | Hold |
|
|||||
|
2016
Q3 | $11K | Hold |
|
|||||
|
2016
Q2 | $7K | Sell |
|
|||||
|
2016
Q1 | $14K | Buy |
|